3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline

C36H25N3 — CID 156900561

IUPAC3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline
SMILESc1ccc(N(c2ccccc2)c2cccc(-c3c4ccccc4n4ccc5c6ccccc6[nH]c5c34)c2)cc1
InChIInChI=1S/C36H25N3/c1-3-13-26(14-4-1)39(27-15-5-2-6-16-27)28-17-11-12-25(24-28)34-31-19-8-10-21-33(31)38-23-22-30-29-18-7-9-20-32(29)37-35(30)36(34)38/h1-24,37H
InChIKeyOCCACTDZJHKUTC-UHFFFAOYSA-N
MW499.62 g/mol
LogP9.86
Rot. Bonds4

About 3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline

3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline (PubChem CID 156900561) has the molecular formula C36H25N3 and a molecular weight of 499.62 g/mol. Its IUPAC name is 3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline.

Molecular Properties

Compound Name3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline
PubChem CID156900561
Molecular FormulaC36H25N3
Molecular Weight499.62 g/mol
Exact Mass499.20
IUPAC Name3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline
SMILESc1ccc(N(c2ccccc2)c2cccc(-c3c4ccccc4n4ccc5c6ccccc6[nH]c5c34)c2)cc1
InChIInChI=1S/C36H25N3/c1-3-13-26(14-4-1)39(27-15-5-2-6-16-27)28-17-11-12-25(24-28)34-31-19-8-10-21-33(31)38-23-22-30-29-18-7-9-20-32(29)37-35(30)36(34)38/h1-24,37H
InChIKeyOCCACTDZJHKUTC-UHFFFAOYSA-N
XLogP9.86
TPSA23.44 Ų
H-Bond Donors1
H-Bond Acceptors2
Rotatable Bonds4
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500499.62
LogP ≤ 59.86
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 102

Analyze 3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline?
The IUPAC name of 3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline (CID 156900561) is 3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline.
What is the SMILES notation for 3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline?
The canonical SMILES for 3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline is c1ccc(N(c2ccccc2)c2cccc(-c3c4ccccc4n4ccc5c6ccccc6[nH]c5c34)c2)cc1.
What is the InChIKey of 3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline?
The InChIKey is OCCACTDZJHKUTC-UHFFFAOYSA-N. The full InChI is InChI=1S/C36H25N3/c1-3-13-26(14-4-1)39(27-15-5-2-6-16-27)28-17-11-12-25(24-28)34-31-19-8-10-21-33(31)38-23-22-30-29-18-7-9-20-32(29)37-35(30)36(34)38/h1-24,37H.
What are the key properties of 3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline?
3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline has a molecular weight of 499.62 g/mol, XLogP of 9.86, 4 rotatable bonds, 1 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(3,13-diazapentacyclo[11.7.0.02,10.04,9.014,19]icosa-1(20),2(10),4,6,8,11,14,16,18-nonaen-20-yl)-N,N-diphenylaniline is sourced from PubChem (CID 156900561), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).